Global Alopecia Treatment Market Projected to Surge to US$ 24.0 Billion by 2033, Meeting Escalating Demand for Hair Loss Solutions: Persistence Market Research

In 2022, the United States held a dominant market share of over 92.2% in the North American alopecia treatment market, and this trend is anticipated to persist throughout the forecast period.

New York, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The global alopecia treatment market is expected to thrive with a CAGR of 5.6% from 2022 to 2033, reaching a total of US$ 24.0 billion by the end of 2033, as reported by Persistence Market Research.

The demand for hair-restoration medications, known for their improved effectiveness and minimal side effects, is driving the growth of the alopecia treatment market. Innovative treatments like cytokine therapy and regenerative cell therapy are gaining popularity in the field of alopecia treatment.

Alopecia is an autoimmune condition where the body's immune system targets healthy hair follicles, causing hair loss. To treat alopecia, various drugs and surgical procedures like hair transplantation and scalp reduction are employed. The alopecia treatment market is projected to witness substantial growth in the coming years. This growth can be attributed to factors such as the increasing incidence of chronic diseases like arthritis, Polycystic Ovary Syndrome (PCOS), and cancer, changes in lifestyle, heightened stress levels, a growing elderly population, hormonal imbalances, poor diets, and a rising demand for alopecia treatment drugs.

The surging demand for drugs and pharmaceuticals to address alopecia is a key driver of this market's growth. Many organizations are investing in research and development to create both oral and topical medications for alopecia treatment in response to the rising demand.

The increasing prevalence of alopecia worldwide is a primary factor contributing to the anticipated growth of the alopecia treatment market in the forecast period.

For more insights into the Market, Request a Sample of this Report - https://www.persistencemarketresearch.com/samples/9677

Market Snapshot:

 Report Coverage

 Details

Market Revenue 2023

US$ 9.2 billion

Estimated Revenue 2023

US$ 24.0 billion

Growth Rate -  CAGR

5.6%

 

Forecast Period

2023-2033

No. of Pages

250 Pages

Market  Segmentation

By Treatment Type, By End User, By Region

Regions Covered

North America, Latin America, Europe, Asia Pacific, Middle East & Africa

Companies Covered

Elli Lilly and Company, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd, Shiseido Co., Ltd., Zhangguang 101 Science & Technology Co., Ltd., Pfizer, Thera dome, LUTRONIC, Curallux

Alopecia Treatment Market Trends

Latest trends in the alopecia treatment market: